Unidade de Imunologia Clínica, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
PLoS Pathog. 2009 Nov;5(11):e1000667. doi: 10.1371/journal.ppat.1000667. Epub 2009 Nov 20.
Plasmacytoid dendritic cells (pDC) provide an important link between innate and acquired immunity, mediating their action mainly through IFN-alpha production. pDC suppress HIV-1 replication, but there is increasing evidence suggesting they may also contribute to the increased levels of cell apoptosis and pan-immune activation associated with disease progression. Although having the same clinical spectrum, HIV-2 infection is characterized by a strikingly lower viremia and a much slower rate of CD4 decline and AIDS progression than HIV-1, irrespective of disease stage. We report here a similar marked reduction in circulating pDC levels in untreated HIV-1 and HIV-2 infections in association with CD4 depletion and T cell activation, in spite of the undetectable viremia found in the majority of HIV-2 patients. Moreover, the same overexpression of CD86 and PD-L1 on circulating pDC was found in both infections irrespective of disease stage or viremia status. Our observation that pDC depletion occurs in HIV-2 infected patients with undetectable viremia indicates that mechanisms other than direct viral infection determine the pDC depletion during persistent infections. However, viremia was associated with an impairment of IFN-alpha production on a per pDC basis upon TLR9 stimulation. These data support the possibility that diminished function in vitro may relate to prior activation by HIV virions in vivo, in agreement with our finding of higher expression levels of the IFN-alpha inducible gene, MxA, in HIV-1 than in HIV-2 individuals. Importantly, serum IFN-alpha levels were not elevated in HIV-2 infected individuals. In conclusion, our data in this unique natural model of "attenuated" HIV immunodeficiency contribute to the understanding of pDC biology in HIV/AIDS pathogenesis, showing that in the absence of detectable viremia a major depletion of circulating pDC in association with a relatively preserved IFN-alpha production does occur.
浆细胞样树突状细胞(pDC)在先天免疫和获得性免疫之间提供了重要的联系,主要通过 IFN-α 的产生来发挥作用。pDC 抑制 HIV-1 的复制,但越来越多的证据表明,它们也可能导致与疾病进展相关的细胞凋亡和全免疫激活水平升高。尽管具有相同的临床特征,但 HIV-2 感染的特点是病毒血症显著降低,CD4 下降和艾滋病进展速度比 HIV-1 慢得多,而与疾病阶段无关。我们在此报告,在未经治疗的 HIV-1 和 HIV-2 感染中,循环 pDC 水平的相似明显降低与 CD4 耗竭和 T 细胞激活有关,尽管大多数 HIV-2 患者的病毒血症无法检测到。此外,在两种感染中,无论疾病阶段或病毒血症状态如何,都发现循环 pDC 上相同的 CD86 和 PD-L1 过度表达。我们的观察结果表明,在 HIV-2 感染患者中,即使病毒血症无法检测到,pDC 耗竭也会发生,这表明在持续感染期间,决定 pDC 耗竭的机制不仅仅是直接的病毒感染。然而,病毒血症与 TLR9 刺激时每 pDC 基础上 IFN-α 产生的受损有关。这些数据支持这样一种可能性,即体外功能下降可能与体内 HIV 病毒粒子的先前激活有关,这与我们在 HIV-1 个体中发现的 IFN-α 诱导基因 MxA 的表达水平高于 HIV-2 个体的发现一致。重要的是,HIV-2 感染个体的血清 IFN-α 水平没有升高。总之,我们在这种独特的“减弱”HIV 免疫缺陷的自然模型中的数据有助于理解 pDC 在 HIV/AIDS 发病机制中的生物学特性,表明在没有可检测到的病毒血症的情况下,循环 pDC 的大量消耗与相对保留的 IFN-α 产生确实会发生。